RESUMO
BACKGROUND: Corticosteroids have been recommended to facilitate rapid recovery after cardiac surgery. We previously reported that dexamethasone given after induction of anesthesia decreases the incidence of postoperative shivering. We performed a post hoc analysis of the data obtained during that study, focusing on secondary outcomes. METHODS: A total of 235 adult patients undergoing elective coronary or valvular heart surgery were randomized to receive dexamethasone 0.6 mg/kg or placebo after induction of anesthesia. Patients who had pharmacologically treated diabetes mellitus, had hypersensitivity to dexamethasone, or were receiving treatment with corticosteroids were excluded. RESULTS: We found that, compared with placebo, patients receiving dexamethasone were more likely to remain tracheally intubated for 6 hours or less (26.4% vs 10.0%, p = 0.020) and had a lower incidence of early postoperative fever (20.2% vs 36.8%, p = 0.009) and new-onset atrial fibrillation during the first 3 days postoperatively (18.9% vs 32.3%, p = 0.027). However, we could not demonstrate a statistical difference in the intensive care unit or hospital length of stay, or in overall morbidity and mortality. The dexamethasone-treated patients were also more likely to have a higher blood glucose on admission to the intensive care unit (186 mg/dL vs 143 mg/dL, p = 0.012). CONCLUSIONS: Dexamethasone facilitates early tracheal extubation and is associated with a lower incidence of early postoperative fever and new-onset atrial fibrillation. Apart from a treatable decreased glucose tolerance, dexamethasone treatment was not shown to affect morbidity or mortality significantly.
Assuntos
Anti-Inflamatórios/administração & dosagem , Procedimentos Cirúrgicos Cardíacos , Dexametasona/administração & dosagem , Anestesia , Fibrilação Atrial/prevenção & controle , Glicemia/análise , Procedimentos Cirúrgicos Eletivos , Feminino , Humanos , Unidades de Terapia Intensiva , Intubação Intratraqueal , Tempo de Internação , Masculino , Pessoa de Meia-Idade , Complicações Pós-Operatórias/prevenção & controle , Resultado do TratamentoAssuntos
Anestésicos Locais/efeitos adversos , Benzocaína/efeitos adversos , Metemoglobinemia/induzido quimicamente , Administração Tópica , Idoso , Anestésicos Locais/administração & dosagem , Benzocaína/administração & dosagem , Broncoscopia , Cuidados Críticos , Feminino , Hérnia Hiatal/cirurgia , Humanos , Intubação IntratraquealRESUMO
As a renal quality management nurse, I am always looking for new and interesting ways to share information and comparative data to educate and motivate fellow renal professionals. The intent of the sharing of the information is to stimulate quality activity. As a quality improvement project this interview with novelist James Michener, a patient with end stage renal disease, provides ANNA Journal readers with an increased understanding of the importance of providing quality care to the lives of people we care for. Recently, Michener provided an excellent opportunity to share his own experience in dealing with renal failure and dialysis therapy. His celebrity status and openness in discussing many issues related to his renal failure furnished a unique quality improvement opportunity.